Vimarsana
Biggest News Aggregation in the World

Page 12 - Affinity Technologies News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Affinity Technologies. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Affinity Technologies Today - Breaking & Trending Today

AMA Issues CPT Code for bioAffinity Technologies' CyPath® Lung Test for Early-Stage Lung Cancer - Vimarsana News

AMA Issues CPT Code for bioAffinity Technologies' CyPath® Lung Test for Early-Stage Lung Cancer

BioAffinity Technologies, Inc. , a biotechnology company addressing the need for noninvasive detection of early-stage lung cancer, today announced that the American Medical Association has released...

AMA Issues CPT Code for bioAffinity Technologies' CyPath® Lung Test for Early-Stage Lung Cancer | Region - Vimarsana News

AMA Issues CPT Code for bioAffinity Technologies' CyPath® Lung Test for Early-Stage Lung Cancer | Region

SAN ANTONIO, Texas--(BUSINESS WIRE)--Jul 12, 2023--

8.2% CAGR for Lung Cancer Screening Market Worth $4.36Bn by - Vimarsana News

8.2% CAGR for Lung Cancer Screening Market Worth $4.36Bn by

By technology, the LDCT segment will account maximum share in lung cancer screening market during 2022-2030. The lung cancer screening industry majorly...

bioAffinity Technologies, Inc. (NASDAQ:BIAFW) Sees Large Increase in Short Interest - Vimarsana News

bioAffinity Technologies, Inc. (NASDAQ:BIAFW) Sees Large Increase in Short Interest

BioAffinity Technologies, Inc. (NASDAQ:BIAFW – Get Rating) was the recipient of a large increase in short interest in May. As of May 31st, there was short interest totalling 6,300 shares, an increase of 6.8% from the May 15th total of 5,900 shares. Based on an average daily trading volume, of 2,900 shares, the days-to-cover ratio […]

Source: wkrb13.com
BioAffinity Technologies Presents Research Findings at UMass RNA Therapeutics Symposium - Vimarsana News

BioAffinity Technologies Presents Research Findings at UMass RNA Therapeutics Symposium

BioAffinity Technologies, Inc. , a biotechnology company addressing the need for early-stage cancer detection and broad-spectrum cancer therapeutics, will present the poster “Vitamin B12... | June 15, 2023